vs
Day One Biopharmaceuticals, Inc.（DAWN）与FIRST UNITED CORP（FUNC）财务数据对比。点击上方公司名可切换其他公司
Day One Biopharmaceuticals, Inc.的季度营收约是FIRST UNITED CORP的1.7倍（$39.8M vs $23.2M），FIRST UNITED CORP净利率更高（24.9% vs -49.6%，领先74.4%），FIRST UNITED CORP同比增速更快（11.9% vs -57.6%）
Day One Biopharmaceuticals是一家临床阶段生物制药公司，专注于为患有基因驱动型癌症的儿童及年轻成人患者开发精准靶向肿瘤疗法，推进创新候选药物研发，满足相关群体未被覆盖的医疗需求，主要在美国市场开展业务。
联合啤酒控股有限公司（又称UB集团）是喜力集团旗下的印度子公司，总部位于卡纳塔克邦班加罗尔的UB城。公司核心业务涵盖酒类饮品生产及多领域投资，是印度最大的啤酒生产商，主打以翠鸟为品牌的啤酒产品，同时拥有多款其他酒类品牌。
DAWN vs FUNC — 直观对比
营收规模更大
DAWN
是对方的1.7倍
$23.2M
营收增速更快
FUNC
高出69.4%
-57.6%
净利率更高
FUNC
高出74.4%
-49.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.8M | $23.2M |
| 净利润 | $-19.7M | $5.8M |
| 毛利率 | — | — |
| 营业利润率 | -60.9% | 32.9% |
| 净利率 | -49.6% | 24.9% |
| 营收同比 | -57.6% | 11.9% |
| 净利润同比 | -153.3% | -6.6% |
| 每股收益（稀释后） | $-0.19 | $0.89 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAWNFUNC
| Q4 25 | — | $23.2M | ||
| Q3 25 | $39.8M | $22.7M | ||
| Q2 25 | $33.9M | $21.8M | ||
| Q1 25 | $30.8M | $20.9M | ||
| Q4 24 | — | $20.8M | ||
| Q3 24 | $93.8M | $20.3M | ||
| Q2 24 | — | $20.1M | ||
| Q1 24 | $0 | $18.7M |
净利润DAWNFUNC
| Q4 25 | — | $5.8M | ||
| Q3 25 | $-19.7M | $6.9M | ||
| Q2 25 | $-30.3M | $6.0M | ||
| Q1 25 | $-36.0M | $5.8M | ||
| Q4 24 | — | $6.2M | ||
| Q3 24 | $37.0M | $5.8M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | $-62.4M | $3.7M |
营业利润率DAWNFUNC
| Q4 25 | — | 32.9% | ||
| Q3 25 | -60.9% | 40.6% | ||
| Q2 25 | -103.1% | 36.5% | ||
| Q1 25 | -133.5% | 36.8% | ||
| Q4 24 | — | 39.2% | ||
| Q3 24 | 31.6% | 38.0% | ||
| Q2 24 | — | 32.5% | ||
| Q1 24 | — | 26.0% |
净利率DAWNFUNC
| Q4 25 | — | 24.9% | ||
| Q3 25 | -49.6% | 30.6% | ||
| Q2 25 | -89.4% | 27.5% | ||
| Q1 25 | -117.0% | 27.7% | ||
| Q4 24 | — | 29.8% | ||
| Q3 24 | 39.5% | 28.5% | ||
| Q2 24 | — | 24.5% | ||
| Q1 24 | — | 19.8% |
每股收益（稀释后）DAWNFUNC
| Q4 25 | — | $0.89 | ||
| Q3 25 | $-0.19 | $1.07 | ||
| Q2 25 | $-0.29 | $0.92 | ||
| Q1 25 | $-0.35 | $0.89 | ||
| Q4 24 | — | $0.95 | ||
| Q3 24 | $0.38 | $0.89 | ||
| Q2 24 | — | $0.75 | ||
| Q1 24 | $-0.72 | $0.56 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $451.6M | $131.6M |
| 总债务越低越好 | — | $95.9M |
| 股东权益账面价值 | $450.9M | $203.6M |
| 总资产 | $513.8M | $2.1B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资DAWNFUNC
| Q4 25 | — | $131.6M | ||
| Q3 25 | $451.6M | $95.2M | ||
| Q2 25 | $453.1M | $79.1M | ||
| Q1 25 | $473.0M | $84.4M | ||
| Q4 24 | — | $78.3M | ||
| Q3 24 | $558.4M | $62.4M | ||
| Q2 24 | — | $45.1M | ||
| Q1 24 | $317.9M | $86.9M |
总债务DAWNFUNC
| Q4 25 | — | $95.9M | ||
| Q3 25 | — | $95.9M | ||
| Q2 25 | — | $120.9M | ||
| Q1 25 | — | $120.9M | ||
| Q4 24 | — | $120.9M | ||
| Q3 24 | — | $120.9M | ||
| Q2 24 | — | $70.9M | ||
| Q1 24 | — | $70.9M |
股东权益DAWNFUNC
| Q4 25 | — | $203.6M | ||
| Q3 25 | $450.9M | $199.1M | ||
| Q2 25 | $460.8M | $191.1M | ||
| Q1 25 | $479.5M | $183.7M | ||
| Q4 24 | — | $179.3M | ||
| Q3 24 | $555.5M | $174.0M | ||
| Q2 24 | — | $164.2M | ||
| Q1 24 | $296.8M | $165.5M |
总资产DAWNFUNC
| Q4 25 | — | $2.1B | ||
| Q3 25 | $513.8M | $2.0B | ||
| Q2 25 | $519.0M | $2.0B | ||
| Q1 25 | $534.4M | $2.0B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | $600.8M | $1.9B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | $326.6M | $1.9B |
负债/权益比DAWNFUNC
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 0.48× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.67× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | 0.43× | ||
| Q1 24 | — | 0.43× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $19.4M |
| 自由现金流经营现金流 - 资本支出 | — | $15.4M |
| 自由现金流率自由现金流/营收 | — | 66.3% |
| 资本支出强度资本支出/营收 | 0.0% | 17.1% |
| 现金转化率经营现金流/净利润 | — | 3.35× |
| 过去12个月自由现金流最近4个季度 | — | $22.7M |
8季度趋势，按日历期对齐
经营现金流DAWNFUNC
| Q4 25 | — | $19.4M | ||
| Q3 25 | $-5.8M | $1.5M | ||
| Q2 25 | $-24.8M | $995.0K | ||
| Q1 25 | $-59.0M | $7.0M | ||
| Q4 24 | — | $22.3M | ||
| Q3 24 | $50.8M | $2.3M | ||
| Q2 24 | — | $7.2M | ||
| Q1 24 | $-49.7M | $3.6M |
自由现金流DAWNFUNC
| Q4 25 | — | $15.4M | ||
| Q3 25 | — | $168.0K | ||
| Q2 25 | $-24.8M | $706.0K | ||
| Q1 25 | $-59.3M | $6.4M | ||
| Q4 24 | — | $20.4M | ||
| Q3 24 | $50.0M | $588.0K | ||
| Q2 24 | — | $7.0M | ||
| Q1 24 | — | $3.5M |
自由现金流率DAWNFUNC
| Q4 25 | — | 66.3% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | -73.2% | 3.2% | ||
| Q1 25 | -192.8% | 30.5% | ||
| Q4 24 | — | 98.1% | ||
| Q3 24 | 53.4% | 2.9% | ||
| Q2 24 | — | 35.1% | ||
| Q1 24 | — | 18.9% |
资本支出强度DAWNFUNC
| Q4 25 | — | 17.1% | ||
| Q3 25 | 0.0% | 5.9% | ||
| Q2 25 | 0.0% | 1.3% | ||
| Q1 25 | 1.0% | 2.8% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | 0.8% | 8.4% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.3% |
现金转化率DAWNFUNC
| Q4 25 | — | 3.35× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 3.60× | ||
| Q3 24 | 1.37× | 0.40× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAWN
| Products | $38.5M | 97% |
| License Agreement With Ipsen Pharma Sas | $1.3M | 3% |
FUNC
| Trust Department | $9.8M | 42% |
| Other | $5.6M | 24% |
| Debit Card Income | $4.1M | 17% |
| Service Charges | $2.3M | 10% |
| Brokerage Commissions | $1.4M | 6% |
